Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
In memoriam: Marion Hendriks-de Jong
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-021-05463-4
document
Eric P. Krenning, Gabriel P. Krestin, Monique R. Bernsen, Simone U. Dalm, Otto C. Boerman, Philip H. Elsinga, Andor W. J. M. Glaudemans, Danielle J. Vugts, Jolanta Kunikowska, Paola A. Erba, Laura Evangelista, Berthold A. Nock, Theodosia Maina
F-18-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization
Published in: Current cardiology reports
Access to document
10.1007/s11886-021-01542-y
document
Purpose of Review Additional imaging modalities, such as FDG-PET/CT, have been included into the workup for patients with suspected infective endocarditis, according to major international guidelines published in 2015. The purpose of this review is to give an overview of FDG-PET/CT indications and standardized approaches in the setting of suspected infective endocarditis. Recent Findings There are two main indications for performing FDG-PET/CT in patients with suspected infective endocarditis: (i) detecting intracardiac infections and (ii) detection of (clinically silent) disseminated infectious disease. The diagnostic performance of FDG-PET/CT for intracardiac...
Value of 18F-FES-PET to solve clinical dilemmas in breast cancer patients: a retrospective study
Published in: Journal of Nuclear Medicine
Access to document
10.2967/jnumed.120.256826
document
Background: Breast cancer (BC) is a heterogeneous disease, in which estrogen receptor (ER) expression plays an important role in the majority of breast tumors. A clinical dilemma may arise when a metastasis biopsy to determine the ER status cannot be performed safely or when ER heterogeneity is suspected between tumor lesions. Whole-body ER imaging, such as 16α-18F-fluoro-17β-estradiol (18F-FES) positron emission tomography (PET), may have added value in these situations. However, the role of this imaging technique in routine clinical practice remains to be further determined. Therefore, we assessed...
Jorianne Boers, Naila Loudini, Celina L Brunsch, Sylvia A Koza, Erik F J de Vries, Andor W J M Glaudemans, Geke A P Hospers, Carolina P Schroder
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
Published in: JACC: Cardiovascular Imaging
Access to document
10.1016/j.jcmg.2021.03.007
document
Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational...
INCAPS COVID Investigators Group, Cole B. Hirschfeld, Leslee J. Shaw, Michelle C. Williams, Ryan Lahey, Todd C. Villines, Sharmila Dorbala, Andrew Choi, Nishant R. Shah, David A. Bluemke, Daniel S. Berman, Ron Blankstein, Maros Ferencik, Jagat Narula, David Winchester, Eli Malkovskiy, Benjamin Goebel, Michael Randazzo, Juan Lopez-Mattei, Purvi ParwaniJoao V. Vitola, Rodrigo Cerci, Nathan Better, Paolo Raggi, Bin Lu, Vladimir Sergienko, Valentin Sinitsyn, Takashi Kudo, Bjarne Linde Nørgaard, Pál Maurovich-Horvat, Yosef Cohen, Thomas N.B. Pascual, Yaroslav Pynda, Maurizio Dondi, Diana Paez, Andrew J. Einstein
F-18-FDG-Uptake in Mediastinal Lymph Nodes in Suspected Prosthetic Valve Endocarditis: Predictor or Confounder?
Published in: Frontiers in cardiovascular medicine
Access to document
10.3389/fcvm.2021.717774
document
Introduction: Prosthetic valve endocarditis (PVE) is a serious disease affecting similar to 0.4% of prosthetic valve recipients per year. F-18-FDG-PET/CT has high sensitivity and specificity for PVE and is included as major criterion for the diagnosis in recent guidelines of the European Society of Cardiology. We addressed the question whether increased FDG-uptake in mediastinal lymph nodes could help to support the visual diagnostic assessment of PVE. Methods: In this sub-analysis of a previously published retrospective multicentre study, 160 unique patients were identified who underwent F-18-FDG-PET/CT for evaluation of...
Derk ten Hove, Bhanu Sinha, Andor W. J. M. Glaudemans, Anna Gomes, Laurens E. Swart, Wilco Tanis, Ricardo P. J. Budde, Riemer H. J. A. Slart